What Is a Digitalis-Induced Arrhythmia: Causes and Clinical Implications

Digitalis-induced arrhythmia refers to abnormal heart rhythms that develop as a result of excessive or toxic levels of cardiac glycosides, primarily digoxin, used to treat heart failure and arrhythmias. These drugs enhance myocardial contractility but can disrupt normal electrical conduction in the heart when concentrations rise too high. The primary mechanism involves digitalis sensitivity to the sodium-potassium ATPase pump, leading to increased intracellular calcium, which triggers irregular impulse formation in the atria and ventricles. Clinically, this often manifests as atrial tachycardia, ventricular tachycardia, or even life-threatening ventricular fibrillation. Understanding and recognizing these arrhythmias is crucial for timely intervention, as prompt dose adjustment or anti-digoxin therapy can prevent serious outcomes. Monitoring drug levels, patient electrolytes, and ECG changes enables effective management and reduces risks associated with digitalis use.

Diagnosis hinges on clinical assessment, ECG findings, and serum digoxin levels, with management focusing on correcting toxicity, controlling heart rate, and preventing recurrence. Patients on digitalis therapy should be educated about symptoms like palpitations, dizziness, or nausea, prompting immediate medical attention. With proper monitoring and adherence to therapeutic ranges, digitalis remains a valuable therapy, but awareness of its arrhythmogenic potential is essential for safe and effective cardiac care.

Conclusion: Digitalis-induced arrhythmia represents a serious complication requiring vigilant monitoring during treatment. Early recognition, precise dosing, and prompt clinical response are key to minimizing risk and ensuring optimal patient outcomes. Healthcare providers must remain alert to signs of toxicity to safeguard those relying on this critical medication.

Recognizing and preventing digitalis-induced arrhythmia is critical for safe cardiac therapy. With vigilant monitoring, patient education, and timely intervention, clinicians can harness the benefits of digoxin while minimizing its arrhythmogenic risks, ensuring optimal outcomes in heart disease management.

Digitalis induced arrhythmia is a heart rhythm disorder triggered by the use or toxicity of digitalis medications, especially digoxin. Digitalis is commonly prescribed to manage heart failure and atrial fibrillation. However, at toxic levels or in sensitive individuals, it can disturb the normal electrical conduction of the heart, leading to abnormal rhythms.

These irregular heartbeats can. Cardiac glycosides (primarily digoxin) are used clinically in two situations: in heart failure with reduced ejection fraction [1,2] and in certain supraventricular tachyarrhythmias [3,4]. This article concerns adverse side effects of digoxin treatment, with emphasis on ECG changes, arrhythmias and conduction disturbances.

Digoxin may cause all known cardiac arrhythmias. Digitalis- induced ventricular arrhythmias can be abolished in the experimental animal by sympathetic ablation or by depletion of the myocardium of norepinephrine; atrial and ventricular arrhythmias have been abolished by beta-adrenergic re- ceptor blockade in both animals and man.121,122 When A-V block is induced by digitalis, however, beta. Acute digitalis toxicity can result from unintentional, suicidal, or homicidal overdose of the digitalis preparation digoxin, or accidental ingestion of plants that contain cardiac glycosides.

Chronic toxicity in patients on digoxin therapy may result from deteriorating renal function, dehydration, electrolyte disturbances, or drug interactions. Abstract Six cases of digitalis intoxication presenting with cardiac arrhythmias are described. Multiple cardiac arrhythmias consisting of multifocal, or unifocal, multiform ventricular ectopic beats, bidirectional tachycardia, complete heart block, accelerated junctional rhythm with exit block, nonparoxysmal junctional tachycardia, atrial fibrillation, atrial tachycardia with block, and.

Nonetheless, digitalis intoxication is still with us and may be just as frequent as in the past. 2 Cardiac arrhythmias are a common presentation of intoxication, and they may require therapy while the intoxication resolves. The arrhythmias of digitalis intoxication arise from two actions of the drug.

Digoxin is a medication derived from the leaves of the foxglove plant. It has been used for over two centuries to treat various heart conditions, particularly heart failure and atrial fibrillation. While digoxin can be effective in controlling heart rate and improving cardiac output, it can also lead to significant side effects, including arrhythmias.

Understanding the relationship between. Supportive care of digitalis toxicity includes hydration with IV fluids, oxygenation and support of ventilatory function, discontinuation of the drug, and, sometimes, the correction of electrolyte imbalances. Effective management also relies on early recognition that a dysrhythmia and/or noncardiac manifestation may be related to digitalis intoxication.

General principles of management include. Digitalis electrophysiology is straightforward by comparison with the impenetrable controversy which surrounds its use in chronic heart failure. In the following account, inotropic effects are mentioned only en passant, and the term digitalis is used to describe all glycoside- like compounds, whether or not derived from digitalis plants.